Abstract
The aim of this study was to validate and evaluate AI-assisted decision support for detecting medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients receiving antiresorptive drug (ARD) treatment. A retrospective dataset of 80 panoramic radiographs from adult subjects was included, comprising 40 multiple myeloma patients treated with ARD and clinically diagnosed with MRONJ, and 40 age- and sex-matched healthy controls. Standardised regions of interest were selected on each image and analysed using a pre-trained convolutional neural network adapted for binary classification of bone status (healthy vs diseased). Model performance was evaluated against clinical diagnosis of MRONJ based on clinical lesions using standard diagnostic metrics and receiver operating characteristic (ROC) analysis. The AI model correctly identified 35/40 diseased cases and all controls, resulting in no false positives and five false negatives. Diagnostic performance showed a sensitivity of 87.5%, specificity of 100%, and overall accuracy of 93.8%, with excellent agreement (κ = 0.875). ROC analysis confirmed strong discriminative ability (AUC = 0.95). These findings suggest that AI-assisted analysis of panoramic radiographs may enhance the detection of MRONJ-related bone changes and support clinical decision-making in patients with multiple myeloma receiving antiresorptive therapy.